Hepatic uptake of polystyrene microspheres in rats: Effect of particle size on intrahepatic distribution

被引:107
作者
Ogawara, K
Yoshida, M
Higaki, K
Kimura, T [1 ]
Shiraishi, K
Nishikawa, M
Takakura, Y
Hashida, M
机构
[1] Okayama Univ, Fac Pharmaceut Sci, Dept Pharmaceut, Okayama 7008530, Japan
[2] Kyoto Univ, Fac Pharmaceut Sci, Dept Drug Delivery Res, Sakyo Ku, Kyoto 6068501, Japan
关键词
polystyrene microsphere; particle size; intrahepatic distribution; reticuloendothelial system; pharmacokinetics;
D O I
10.1016/S0168-3659(99)00015-2
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The in vivo disposition of polystyrene microsphere (MS) with the particle: size of 50 nm (MS-50) or 500 nm (MS-500) was characterized after intravenous administration to rats. A rapid elimination from systemic circulation was observed for both MSs. Tissue distribution of MS-50 and MS-500 at 1 h after intravenous injection indicated that both MSs were exclusively distributed to liver and that small but significant amounts of. MS-50 and MS-500 were also distributed to lung and spleen, respectively. To investigate the intrahepatic distribution of MS, liver was separated into liver parenchymal cells (PC) and non-parenchymal cells (NPC) at 1 or 6 h after intravenous administration. The contribution of each cell fraction was dependent on both the size of MS and the lime after administration. Furthermore, by separating the NPC into endothelial cells and Kupffer cells using a centrifugal elutriation method, their contribution was also evaluated. For both MSs, Kupffer cells were recognized to be mostly responsible for the hepatic uptake, although a significant amount of MS-50 (about 28% of total uptake) was taken up by PC. On the other hand, there was little contribution of PC (about 5%) to the hepatic uptake of MS-500. The endothelial cells were contributed larger to the uptake of MS-500 (about 24%) than that of MS-50 (13%). (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:15 / 22
页数:8
相关论文
共 29 条
[1]  
BERG T, 1983, IODINATED DENSITY GR, P173
[2]   UPTAKE AND DEGRADATION OF BOVINE TESTES BETA-GALACTOSIDASE BY PARENCHYMAL AND NONPARENCHYMAL RAT-LIVER CELLS [J].
BLOMHOFF, R ;
BLOMHOFF, HK ;
TOLLESHAUG, H ;
CHRISTENSEN, TB ;
BERG, T .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY, 1985, 17 (12) :1321-1328
[3]  
DALEN PV, 1982, SINUSOIDAL LIVER CEL, P271
[4]  
FAHIMI HD, 1982, LIVER BIOL PATHOBIOL, P495
[5]   Pharmacokinetic analysis of scavenger receptor-mediated uptake of anionized proteins in the isolated perfused rat liver [J].
Furitsu, H ;
Ogawara, K ;
Fujita, T ;
Yamashita, F ;
Takakura, Y ;
Sezaki, H ;
Hashida, M .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 151 (01) :15-26
[6]  
Gatmaitan Z, 1996, AM J PATHOL, V148, P2027
[7]  
GREGORIADIS G, 1988, LIPOSOMES DRUG CARRI
[8]   Development and pharmacokinetics of galactosylated poly-L-glutamic acid as a biodegradable carrier for liver-specific drug delivery [J].
Hirabayashi, H ;
Nishikawa, M ;
Takakura, Y ;
Hashida, M .
PHARMACEUTICAL RESEARCH, 1996, 13 (06) :880-884
[9]   THE ORGAN UPTAKE OF INTRAVENOUSLY ADMINISTERED COLLOIDAL PARTICLES CAN BE ALTERED USING A NON-IONIC SURFACTANT (POLOXAMER-338) [J].
ILLUM, L ;
DAVIS, SS .
FEBS LETTERS, 1984, 167 (01) :79-82
[10]   EFFECT OF A SELECTED SUPPRESSION OF THE RETICULOENDOTHELIAL SYSTEM ON THE DISTRIBUTION OF MODEL CARRIER PARTICLES [J].
ILLUM, L ;
THOMAS, NW ;
DAVIS, SS .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1986, 75 (01) :16-22